Showing 1-5 of 15 :
Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials

Register to watch>> Join a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data. Extracting as much information as possible from real-world datasets is essential for understanding the complete patient journey. Subtle patterns in[…]

Using AI to Expand Treatment Access and Close Guideline Gaps

Tue, Jun 20, 2023 11:00 AM – 12:00 PM EDT Presenters: Costas Boussios, Chief Data Scientist and Joseph Zabinski, Managing Director of AI & Personalized Medicine Register>> Across many conditions, screening for diagnosis and use of effective therapies remain far behind where best-practice clinical guidelines would suggest. Patients falling into this ‘guidelines gap’ may not[…]

Using AI to Accelerate Diagnosis and Treatment

In this episode of the Medical Affairs Professional Society (MAPS) podcast ELEVATE, Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 discusses how Artificial Intelligence can accelerate diagnosis and treatment. Listen to the Full Episode >>

Advancing Personalized Medicine for Health Plans: How AI and RWE can improve outcomes, reduce costs, and improve member engageme

Tue, Oct 18, 2022 11:00 AM – 12:00 PM EDT Presenter: Joseph Zabinski, Senior Director, AI & Precision Medicine, OM1 Register >> As population health moves towards personalized, precision medicine, optimizing treatment options and reducing ineffective care will be critical to plans’ success and differentiation in highly competitive environments. Real-world evidence drawn from deep datasets[…]

Using Real-World Data to Unlock Better Outcomes in IBD & NASH Patients

Gastrointestinal and metabolic disorders are highly prevalent and result in reduced quality of life for many patients. Treatments are aimed at reducing symptoms and preventing complications and progression. More research is needed to better understand natural history and progression, treatment effectiveness, and outcomes. Register here Linked real-world data (RWD) and machine learning (ML) applications provide[…]